Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Olson

Showing results (21-30 of 66) with videos related to

Pageof 7
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|December 9, 2003
Adipose-specific peroxisome proliferator-activated receptor gamma knockout causes insulin resistance in fat and liver but not in muscleWeimin He, Yaacov Barak, Andrea Hevener, et al.
Genes & Development|September 18, 2009
MicroRNA dynamics in the stages of tumorigenesis correlate with hallmark capabilities of cancerPeter Olson, Jun Lu, Hao Zhang, et al.
Genes & Development|March 24, 2004
PPAR gamma signaling exacerbates mammary gland tumor developmentEnrique Saez, John Rosenfeld, Antonia Livolsi, et al.
Molecular Cancer Therapeutics|May 20, 2017
Notch Inhibitor PF-03084014 Inhibits Hepatocellular Carcinoma Growth and Metastasis via Suppression of Cancer Stemness due to Reduced Activation of Notch1-Stat3Chuan Xing Wu, Aimin Xu, Cathy C Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 8, 2015
PEST domain mutations in Notch receptors comprise an oncogenic driver segment in triple-negative breast cancer sensitive to a γ-secretase inhibitorKai Wang, Qin Zhang, Danan Li, et al.
Cancer Immunology, Immunotherapy : CII|November 11, 2017
The class I/IV HDAC inhibitor mocetinostat increases tumor antigen presentation, decreases immune suppressive cell types and augments checkpoint inhibitor therapyDavid Briere, Niranjan Sudhakar, David M Woods, et al.
Comparative Medicine|December 12, 2013
Contrast agents for quantitative microCT of lung tumors in miceKush Lalwani, Anand Giddabasappa, Danan Li, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 24, 2006
PPARdelta regulates glucose metabolism and insulin sensitivityChih-Hao Lee, Peter Olson, Andrea Hevener, et al.
Genes & Development|November 23, 2006
Smad4 is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancerNabeel Bardeesy, Kuang-Hung Cheng, Justin H Berger, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|October 16, 2014
Ex vivo cardiovascular magnetic resonance measurements of right and left ventricular mass compared with direct mass measurement in excised hearts after transplantation: a first human SSFP comparisonNicholas J Farber, Sahadev T Reddy, Mark Doyle, et al.
Pageof 7

Showing results (21-30 of 66) with videos related to

Sort By:
Pageof 7
Proceedings of the National Academy of Sciences of the United States of America|December 9, 2003
Adipose-specific peroxisome proliferator-activated receptor gamma knockout causes insulin resistance in fat and liver but not in muscleWeimin He, Yaacov Barak, Andrea Hevener, et al.
Genes & Development|September 18, 2009
MicroRNA dynamics in the stages of tumorigenesis correlate with hallmark capabilities of cancerPeter Olson, Jun Lu, Hao Zhang, et al.
Genes & Development|March 24, 2004
PPAR gamma signaling exacerbates mammary gland tumor developmentEnrique Saez, John Rosenfeld, Antonia Livolsi, et al.
Molecular Cancer Therapeutics|May 20, 2017
Notch Inhibitor PF-03084014 Inhibits Hepatocellular Carcinoma Growth and Metastasis via Suppression of Cancer Stemness due to Reduced Activation of Notch1-Stat3Chuan Xing Wu, Aimin Xu, Cathy C Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 8, 2015
PEST domain mutations in Notch receptors comprise an oncogenic driver segment in triple-negative breast cancer sensitive to a γ-secretase inhibitorKai Wang, Qin Zhang, Danan Li, et al.
Cancer Immunology, Immunotherapy : CII|November 11, 2017
The class I/IV HDAC inhibitor mocetinostat increases tumor antigen presentation, decreases immune suppressive cell types and augments checkpoint inhibitor therapyDavid Briere, Niranjan Sudhakar, David M Woods, et al.
Comparative Medicine|December 12, 2013
Contrast agents for quantitative microCT of lung tumors in miceKush Lalwani, Anand Giddabasappa, Danan Li, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 24, 2006
PPARdelta regulates glucose metabolism and insulin sensitivityChih-Hao Lee, Peter Olson, Andrea Hevener, et al.
Genes & Development|November 23, 2006
Smad4 is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancerNabeel Bardeesy, Kuang-Hung Cheng, Justin H Berger, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|October 16, 2014
Ex vivo cardiovascular magnetic resonance measurements of right and left ventricular mass compared with direct mass measurement in excised hearts after transplantation: a first human SSFP comparisonNicholas J Farber, Sahadev T Reddy, Mark Doyle, et al.
Pageof 7